nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-A4149162·Framework v5.0·Pipeline v0.4·Evaluated 12 Jun 2026·OECD: 1.3 Physical Sciences·Subfield: Molecular Biology·Basis: Full text·Type: Laboratory experiment

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

Martin Jínek et al.Martin Jínek, Krzysztof Chylinski, Ines Fonfara et al.·2012·10.1126/science.1225829 ↗

In brief

A landmark biochemical dissection that establishes RNA-programmable Cas9 and the single-guide design, with the unbridged in vitro-to-cellular gap as its only meaningful constraint.

ReliabilityCaveats4 of 4 checks completeRead the entry ↓
Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems provide bacteria and archaea with adaptive immunity against viruses and plasmids by using CRISPR RNAs (crRNAs) to guide the silencing of invading nucleic acids. We show here that in a subset of these systems, the mature crRNA that is base-paired to trans-activating crRNA (tracrRNA) forms a two-RNA structure that directs the CRISPR-associated protein Cas9 to introduce double-stranded (ds) breaks in target DNA. At sites complementary to the crRNA-guide sequence, the Cas9 HNH nuclease domain cleaves the complementary strand, whereas the Cas9 RuvC-like domain cleaves the noncomplementary strand. The dual-tracrRNA:crRNA, when engineered as a single RNA chimera, also directs sequence-specific Cas9 dsDNA cleavage. Our study reveals a family of endonucleases that use dual-RNAs for site-specific DNA cleavage and highlights the potential to exploit the system for RNA-programmable genome editing.

Strengths · Limitations

Strengths

#contribution

Single-guide RNA enables programmable cleavage

The fusion of crRNA and tracrRNA into one chimeric transcript, validated against five independent GFP targets, is the enabling innovation behind programmable DNA cutting.

↳ Fig. 5B-D

#methodological rigour

Orthogonal evidence for each mechanism

Domain-specific catalytic mutants (D10A, H840A) cleanly assign strand-specific cleavage, and a systematic truncation series maps the minimal functional RNA requirements.

↳ Fig. 2; Fig. 3A-C

#application pathway

Directly enables an active research trajectory

The work fills the mechanistic gap left by prior in vivo studies and supplies the precise sgRNA design that downstream cellular and therapeutic applications required.

↳ Conclusions; Introduction refs 25-27, 35-38

Limitations

#application pathway

Cellular editing not yet demonstrated

The system is demonstrated only in a cell-free biochemical setting; genome editing in cells is framed as a possibility, leaving the translation gap unbridged at publication.

↳ Conclusions

#positioning

Patent disclosure placement

A related patent filing by the authors is disclosed in the acknowledgments rather than in a formal competing-interests statement, the placement modern standards expect.

↳ Acknowledgments

#methodological rigour

Limited kinetic and imprecise cleavage mapping

Kinetic characterization is largely confined to single-turnover conditions, and the noncomplementary strand cleavage position is described imprecisely relative to the precise complementary strand mapping.

↳ fig. S6; main text p. 817

Does this match your read? Add your assessment ↓

Nabu Commentary

The adjudicated scores reflect a biochemically rigorous study in which each mechanistic claim is backed by multiple converging experiments, from domain-specific catalytic mutants to truncation series and PAM mutagenesis. The standout contribution is the single chimeric guide RNA validated against five independent targets, which the authors correctly frame as enabling rather than demonstrating cellular genome editing. Evaluation converged strongly on Quality and diverged only on how far the in vitro single-guide prototype advances real-world readiness; this was settled at a middle value that credits the working prototype while recognizing the unbridged cellular gap the authors themselves flag. Reliability is Amber on a narrow point: the authors' related patent is disclosed in the acknowledgments rather than a dedicated competing-interests section, which does not affect the validity of the findings.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
4.7±0.1

Contribution
4.9

The score reflects a transformative advance that biochemically characterizes the dual-RNA Cas9 mechanism and introduces the single-guide RNA design enabling programmable DNA cleavage, with claims carefully proportioned to in vitro evidence. The advance over prior in vivo work is substantial and comprehensive.

Fig. 5 (single chimeric RNA); Figs. 1-4 (mechanistic dissection); Conclusions

the Cas9 endonuclease can be programmed with guide RNA engineered as a single transcript to target and cleave any dsDNA sequence of interest

Methodological Rigour
4.6

The score reflects exemplary biochemical execution with multiple orthogonal lines of evidence per claim, including domain-specific catalytic mutants and systematic truncation series, tempered by limited kinetic characterization and one imprecise cleavage-position description. The Amber reliability flag does not cap Methodological Rigour.

Fig. 2 (D10A/H840A mutants); Fig. 3A-C (truncation series); fig. S6 (kinetics)

the Cas9 HNH domain cleaves the complementary DNA strand, whereas the Cas9 RuvC-like domain cleaves the noncomplementary DNA strand

Reporting
4.7

The score reflects a logically structured narrative progressing from CRISPR biology through mechanism to chimeric RNA design, with effective schematics and proportional translational language; only minor imprecision in describing noncomplementary strand cleavage positions detracts.

Figs. 1E, 5A (schematics); Conclusions section

at one or more sites within three to eight base pairs upstream of the PAM

Positioning
4.5

The score reflects clear positioning within the CRISPR type I/II/III literature and against ZFN/TALEN genome-editing tools, with acknowledged boundary conditions; the absence of a dedicated limitations paragraph and of any off-target discussion limits it slightly, though off-target effects were not yet a field concern.

Introduction (refs 1-27); Conclusions (refs 35-38); fig. S11

Zinc-finger nucleases and transcription-activator-like effector nucleases have attracted considerable interest

Reliability

Caveats4 of 4 checks


Internal CoherenceClean

Abstract, figures, and conclusions are mutually consistent; mechanistic claims (dual-RNA guidance, strand-specific domain assignment, PAM dependence, seed sensitivity, single-guide chimera) are each supported by corresponding figures, with no internal numerical inconsistencies or methods-results mismatches identified.

Research ConductNoted

A related patent filing by the authors is disclosed in the acknowledgments rather than in a formal competing-interests section, which is the placement modern standards would expect. No ethics approval is required for this in vitro biochemical work, and no image-integrity or unverifiable-claim concerns are apparent.

Reference IntegrityClean

All 48 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaProducts and technology · SDG 9
Type of advanceMethodological
Route to useSuggested
AdvanceAdvances
CitationsFWCI 191.5
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The cleavage mechanism and programmability are pinned down only in controlled in vitro reactions using purified Cas9 protein and DNA substrates.

From the paper
“We propose an alternative methodology based on RNA-programmed Cas9 that could offer considerable potential for gene-targeting and genome-editing applications.”

The paper names genome editing as a prospective real-world use of its findings but does not name who would act on them or where.

Pathway

Biologists and biotechnology developers would adapt RNA-programmed Cas9 into a versatile genome-editing tool for modifying genes in cells and organisms.

Barrier

Nothing yet shows the chimeric guide RNA directing Cas9 cleavage inside living cells of target organisms, nor its specificity and safety for editing genomes.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. A noncontiguous code for RNA-guided DNA recognition at the origin of CRISPR-Cas

    Yoon, Loi, Zhang, et al. · 2026 · Biological sciences

    Primary claim

    Unlike canonical guide RNAs that pair with target nucleic acids through contiguous complementarity, vrRNAs recognize double-stranded DNA through a noncontiguous code in which the variable NN dinucleotides collectively specify a gapped target sequence.

    Well-supported
    Evidence Score
    3.9±0.1
    Reliability
    No concerns
  2. Platelet-derived factors dysregulate placental sphingosine-1-phosphate receptor 2 in human trophoblasts

    Freya Lyssy, Jacqueline Guettler, Beatrice A Brugger, et al. · 2023 · Basic medicine

    Primary claim

    S1PR2 was found to be significantly down-regulated in BeWo cells when co-incubated with platelet-derived factors (P = 0.0055).

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats
  3. The endogenous exposome of the pregnant mother: Placental extracellular vesicles and their effect on the maternal system

    Nadja Kupper, Berthold Huppertz · 2021 · Basic medicine

    Primary claim

    in pregnancy pathologies such as preeclampsia, quantity and quality of the placenta-derived vesicles are altered leading to a deleterious effect on the maternal vascular system.

    Tentative
    Evidence Score
    3.2±0.1
    Reliability
    Caveats

How the rubric works →